Nanocurcumin Preparation for Reducing Vcam-1 and IL-6 in High Fat Diet-Induced Hyperlipidemic Rats

Dimas Adhi Pradana; Maulana Ardhi; Arifa Caryn Dea Utami Hasyono; Dzihni Meytasari; Farah Deastasa Nabilah; Rochmy Istikharah; Lutfi Chabib

doi:10.14499/indonesianjpharm30iss1pp58

Nanocurcumin Preparation for Reducing Vcam-1 and IL-6 in High Fat Diet-Induced Hyperlipidemic Rats

Dimas Adhi Pradana, Maulana Ardhi, Arifa Caryn Dea Utami Hasyono, Dzihni Meytasari, Farah Deastasa Nabilah, Rochmy Istikharah, Lutfi Chabib

Abstract

Hyperlipidemia is a pathological condition due to lipid metabolism abnormalities. Increased and oxidized LDL in hyperlipidemia will trigger an inflammatory response and produce proinflammatory cytokines, such as vascular cell adhesion molecule-1 (VCAM-1) and Interleukin-6 (IL-6). Curcumin can be used as antioxidants, anti-inflammatory and antihyperlipidemia, but as it is practically insoluble in water, formulation of curcumin nanosuspension is made to improve the effects of curcumin therapy. This study was conducted to determine the activities of nanocurcumin preparation as preventive measures for rats induced with hyperlipidemia. The test animals used were 49 male Wistar rats divided into 7 test groups: normal control group, negative control group, 80mg/kg BW/day curcumin control group, and nanosuspension curcumin dose of 80mg/kg BW/day, nanoemulsion curcumin dose of 80mg/kg BW/day, SNEDDS curcumin dose of 80mg/kg BW/day and solid lipid nanoparticles dose of 80mg/kg BW/day. Provision of preventive measure was performed on days 1-67. On day 11-67, the induction of lard and egg yolk (1:1) was administered with a volume of 2mL/200g of rat BW. On the 68^th day, blood samples were taken for the determination of VCAM-1 and IL-6 parameters using Biotin-Streptavidin-Amplified Enzyme-Linked Immuno-sorbent Assay method. Data analysis of VCAM-1 and IL-6 levels between test groups were conducted by means of normality test and One-way ANOVA (p<0.05). Based on the data of VCAM-1 and IL-6 levels, nanocurcumin dose of 80mg/kg BW preparation was able to significantly improve the preventive activity of curcumin compared to curcumin suspension dose of 80mg/kg BW by reducing VCAM-1 levels in SNEDDS (53.260%), nanoemulsion (52.737%), nanosuspension (52.325%) and solid lipid nanoparticles (51.444%) and decreasing IL-6 levels in SNEDDS (33.030%), nanoemulsion (31.568%), nanosuspension (29.898%), and solid lipid nanoparticles (28.875%).

Keywords

Atherosclerosis, curcumin, SNEDDS, nanosuspension, nanoemulsion, solid lipid nano, VCAM-1, IL-6, preventive measure

Full Text:

PDF

References

Abdassah Nanopartikel dengan Gelasi Ionik. Farmaka. 15(1):45–52.

Bagiana IK. 2014. Pengembangan Nanogamavuton-0 dengan Formulasi SNEDDS sebagai Kandidat Obat Analgetik dan Antiinflamasi [Tesis]. Yogyakarta: Universitas Gadjah Mada

Basnet P., and Skalko-Basnet N. 2011. Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment. Molecules, 16(6), 4567–4598.

Carvalho D de M., Takeuchi KP., Geraldine RM., Moura CJ de., and Torres MCL. 2015. Production, solubility and antioxidant activity of curcumin nanosuspension. Food Science and Technology (Campinas), 35(1), 115–119.

Chabib L., Martien R., and Ismail H. 2012. Formulation Of Nanocurcumin Using Low Viscosity Chitosan Polymer And Its Cellular Uptake Study Into T47d Cells, Indonesian Jl Pharm. 23(1) : 27-35.

Hansson GK. 2005. Inflammation, Atherosclerosis, and Coronary Artery Disease. The New England J.f Medicine. 352:1685-1695.

Kawasaki K., Muroyama K., Yamamoto N., and Murosaki S. 2015. A hot water extract of Curcuma longa inhibits adhesion molecule protein expression and monocyte adhesion to TNF-α-stimulated human endothelial cells. Bioscience, Biotechnology, and Biochemistry, 79(10), 1654–1659.

Kemenkes. 2013. Pusat Data dan Informasi Kementrian Kesehatan Republik Indonesia diambil dari: URL: http://www.depkes.go.id/article/view/17073100005/penyakit-jantung- penyebab-kematian-tertinggi- kemenkes-ingatkan-cerdik.

Lagonah R. 2014. Formulasi Sediaan Nanoemulsi Ibuprofen dengan Kombinasi Surfaktan Tween 80 dan Lesitin serta Uji Permeasi In Vitro [skripsi]. Universitas Islam Indonesia, Yogyakarta.

Lazaridis N., Alexopoulos AH., Chatzi EG., and Kiparissides C. 1999. Steric stabilization in emulsion polymerization using oligomeric nonionic surfactants. Chemical Engineering Science, 54(15), 3251–3261.

Libby P. 2005. Prevention and Treatment of Atherosclerosis in Harrison’s Principles of Internal Medicine (16 ed., hlm. 1430–1434). The McGraw-Hill Companies, US.

Makadia HA., Bhatt AY., Parmar RB., Paun MJS., and Tank HM. 2013. Self-nano Emulsifying Drug Delivery System (SNEDDS): Future Aspects. AJPR, 3(1), 20–26.

Mujib MA. 2011. Pencirian nano Partikel Kurkuminoid Tersalut Lemak Padat [skripsi]. Institut Pertanian Bogor, Bogor.

Murwani S., Ali M., and Muliartha K. 2013. Diet aterogenik pada tikus putih (Rattus novergicus strain Wistar) sebagai model hewan aterosklerosis. J. Kedokt. Brawijaya. 22:6–9.

Nasr A., Gardouh A., Ghonaim H., Abdelghany E., and Ghorab M. 2016. Effect Of Oils, Surfactants And Cosurfactants On Phase Behavior And Physicochemical Properties Of Self-Nanoemulsifying Drug Delivery System (Snedds) For Irbesartan And Olmesartan. International Journal of Applied Pharmaceutics, 8(1) : 13–24.

Nelson RH. 2013. Hyperlipidemia as a Risk Factor for Cardiovascular Disease. Primary care, 40(1), 195–211.

Nurtamin T. 2014. Potensi Curcumin untuk Mencegah Aterosklerosis. Dalam Continuing Professional Development. Ikatan Apoteker Indonesia.41(8):633–635.

Omoigui S. 2007. The Interleukin-6 inflammation pathway from cholesterol to aging – Role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases. Immunity & Ageing, 4(1): 1-22.

Ricvan DN. 2015. Meta analisis faktor risiko penyakit jantung koroner di Asia Tenggara. [Tesis]. Fakultas Kesehatan Masyarakat Universitas Andalas, Padang. p. 35.

Rosen MJ. 2004. Surfactants and interfacial phenomena (3rd ed). Hoboken, N.J: Wiley-Interscience.

Rosidi A., Khomsan A., Setiawan B., Riyadi H., and Briawan D. 2014. Potensi Temulawak (Curcuma xanthorrhiza Roxb) Sebagai Antioksidan. Laporan Penelitian. Prosiding Seminar Nasional dan Internasional Semarang. p. 1-8.

Sa’adah NN Pratiwi R. 2016. Profil Lipid dan Indeks Aterogenik Tikus Putih(Rattus norvegicus) Hiperlipidemia dengan Asupan Pelet Nasi dan Bekatul Beras Hitam (Oryza sativa L.). Semin. Nas. Biodiversitas VI:3–4.

Shakeel F., Haq N., El-Badry M., Alanazi FK., and Alsarra IA. 2013. Ultra fine super self-nanoemulsifying drug delivery system (SNEDDS) enhanced solubility and dissolution of indomethacin. Journal of Molecular Liquids, Complete(180), 89–94.

Shin S-K., Ha T-Y., McGregor RA., and Choi M-S. 2011. Long‐term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Molecular Nutrition & Food Research, 55(12), 1829–1840.

Sumardika I. 2012. Water Extract of Sweet Potato Leaf Improved Lipid Profile and Blood SOD Content of Rats with High Cholesterol Diet. Medicina (Mex.), (43(2):67-71.).

Tanuwidjojo S. 2005. Pathogenesis of Atherosclerosis: The Role of Inflamation. Kumpulan naskah Semarang Cardiology Up date: New Trends in Cardiovascular Pharmacotherapy. Badan Penerbit Undip, Semarang.p 118-120.

XpressBio. 2018a. Rat IL-6 (Interleukin-6) Elisa kit. Express Biotech International.

XpressBio. 2018b. Rat VCAM-1 Elisa Kit. Express Biotech International.

Yanti Stephanie Yuliani Winarno FG., and Suhartono MT. 2014. Inhibition of Interleukin-6 Expression by Curcumin in Rat Vascular Smooth Muscle Explants In Vitro. American Journal of Biochemistry and Biotechnology, 10(4), 260–266.

DOI: http://dx.doi.org/10.14499/indonesianjpharm30iss1pp58